A Phase 1 Study of FlecIH-103 (Flecainide Acetate Inhalation Solution) Administered Using an Investigational, Single Use, Vibrating Mesh Nebulizer Delivery System to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
A Phase 1, Open-Label, Randomized, Single Dose Study of Flecainide Acetate Inhalation Solution (FlecIH-103) to Flecainide Acetate Intravenous Infusion (Tambocor®) to Compare Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
A Phase 1, Open-Label, Single Ascending Dose Study of FlecIH-104 (Flecainide Acetate Inhalation Solution) to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
100 项与 InCarda Therapeutics Australia Pty Ltd. 相关的临床结果
0 项与 InCarda Therapeutics Australia Pty Ltd. 相关的专利（医药）
100 项与 InCarda Therapeutics Australia Pty Ltd. 相关的药物交易
100 项与 InCarda Therapeutics Australia Pty Ltd. 相关的转化医学
